Quinapril Hydrochloride and Hydrochlorothiazide (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Quinapril Hydrochloride and Hydrochlorothiazide drug offered from Ranbaxy Pharmaceuticals Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Quinapril Hydrochloride and Hydrochlorothiazide |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-03-04 |
| END MARKETING DATE: | 0000-00-00 |
Quinapril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quinapril Hydrochloride and Hydrochlorothiazide from Ranbaxy Pharmaceuticals Inc. |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2009-03-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-161_91baf595-84c1-47db-89b2-e6590d282dec |
| PRODUCT NDC: | 63304-161 |
| APPLICATION NUMBER: | ANDA078211 |
Other HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
